Q6CLH6
Gene name |
ATP25 (KLLA0F02948g) |
Protein name |
ATPase synthesis protein 25, mitochondrial |
Names |
|
Species |
Kluyveromyces lactis (strain ATCC 8585 / CBS 2359 / DSM 70799 / NBRC 1267 / NRRL Y-1140 / WM37) (Yeast) (Candida sphaerica) |
KEGG Pathway |
kla:KLLA0_F02948g |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for Q6CLH6
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-Q6CLH6-F1 | Predicted | AlphaFoldDB |
No variants for Q6CLH6
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| No variants for Q6CLH6 | |||||
No associated diseases with Q6CLH6
8 regional properties for Q6CLH6
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| domain | Dbl homology (DH) domain | 240 - 420 | IPR000219 |
| conserved_site | Guanine-nucleotide dissociation stimulator, CDC24, conserved site | 368 - 393 | IPR001331 |
| domain | SH3 domain | 159 - 218 | IPR001452 |
| domain | Calponin homology domain | 1 - 111 | IPR001715 |
| domain | Pleckstrin homology domain | 442 - 549 | IPR001849 |
| domain | Rho guanine nucleotide exchange factor 6/7, coiled-coil domain | 680 - 763 | IPR032409 |
| domain | Rho guanine nucleotide exchange factor 6, SH3 domain | 161 - 217 | IPR035788 |
| domain | RhoGEF 6/7, PH domain | 449 - 547 | IPR046376 |
1 GO annotations of cellular component
| Name | Definition |
|---|---|
| mitochondrial inner membrane | The inner, i.e. lumen-facing, lipid bilayer of the mitochondrial envelope. It is highly folded to form cristae. |
No GO annotations of molecular function
| Name | Definition |
|---|---|
| No GO annotations for molecular function |
2 GO annotations of biological process
| Name | Definition |
|---|---|
| mitochondrial gene expression | The process in which a mitochondrial gene's sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form. |
| mRNA stabilization | Prevention of degradation of mRNA molecules. In the absence of compensating changes in other processes, the slowing of mRNA degradation can result in an overall increase in the population of active mRNA molecules. |
No homologous proteins in AiPD
| UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
|---|---|---|---|---|
| No homologous proteins | ||||
| 10 | 20 | 30 | 40 | 50 | 60 |
| MHRSYAVLLR | NNVARLCYRP | GSTLFIRNFT | TRHSLRQSKP | WYLDISENKE | EDSNSPFIKP |
| 70 | 80 | 90 | 100 | 110 | 120 |
| IRFPPTEIPA | SLETISKYLN | DKLAVTDIVV | FDTAHSSSAT | SIQSMASYVL | IGTVKSFRHL |
| 130 | 140 | 150 | 160 | 170 | 180 |
| QNCNDELIKF | IKETFDEVPK | SEGLVTSGIL | RKRQRRLGRK | TNLGKIAKIE | NDESGWCLID |
| 190 | 200 | 210 | 220 | 230 | 240 |
| SNVDGLFINI | MTEERRDDLN | LEELYCRVEE | LDQYKKQINL | NPPAEEEDDV | LLGLRKLMMK |
| 250 | 260 | 270 | 280 | 290 | 300 |
| NTKRYYSTVG | ESPKPTFLEA | LTIQDLDSAS | KLIKEEKKPY | HVIASALGRL | PNHIELDAEN |
| 310 | 320 | 330 | 340 | 350 | 360 |
| WIKLFNEATP | TEGPLDYEYW | GARFKFFQLL | YISKRNNIEE | NTQLDASTIK | EFNRELNYFI |
| 370 | 380 | 390 | 400 | 410 | 420 |
| NDFFRFKQLA | LCQPTREELI | GFLEICIQHL | KLSKSYNQLI | SVNMWILKAL | QSYQYSDPKV |
| 430 | 440 | 450 | 460 | 470 | 480 |
| VHDPRVIKLL | VKSMHTENTN | LNSLYEYVNL | ITNEFEVRSL | TNDVIKEIIT | TLVESENWPT |
| 490 | 500 | 510 | 520 | 530 | 540 |
| LFKFWKQCLC | ESAVDSNVWD | FFIKSLLNKN | DKVILSDIVD | NGHLLWIHRS | KLVISDDLKA |
| 550 | 560 | ||||
| SLSKLLDRVD | GSHTNIKKLL | KL |